US Stock MarketDetailed Quotes

BIOA BioAge Labs

Watchlist
  • 18.360
  • -0.040-0.22%
Trading Nov 21 14:14 ET
658.18MMarket Cap-8852P/E (TTM)

BioAge Labs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-92.34%-14.93M
-42.24%-15.78M
-56.70%-15.67M
-3.26%-37.36M
-8.5M
-7.76M
-11.1M
-10M
-36.18M
Net income from continuing operations
-60.05%-23.41M
20.98%-13.58M
-17.21%-12.99M
-60.75%-63.85M
---20.96M
---14.63M
---17.19M
---11.08M
---39.72M
Operating gains losses
-89.21%306K
-96.59%70K
1,128.57%258K
43,973.91%10.09M
--5.18M
--2.84M
--2.05M
--21K
---23K
Depreciation and amortization
-20.83%38K
22.50%49K
0.00%33K
25.58%162K
--41K
--48K
--40K
--33K
--129K
Other non cash items
-97.26%53K
-97.01%60K
37.03%877K
6,413.00%6.51M
--1.94M
--1.93M
--2M
--640K
--100K
Change In working capital
382.65%6.23M
-418.53%-3.94M
-1,262.32%-4.7M
744.03%6.71M
--4.53M
--1.29M
--1.24M
---345K
--795K
-Change in prepaid assets
-127.38%-23K
-87.91%-684K
-794.07%-937K
223.33%37K
--182K
--84K
---364K
--135K
---30K
-Change in payables and accrued expense
553.09%9.54M
-301.75%-3.23M
-683.96%-3.76M
605.07%3.34M
--4.32M
---2.11M
--1.6M
---480K
--473K
-Change in other current assets
----
----
----
-92.90%25K
----
----
----
----
--352K
-Change in other working capital
----
----
----
--3.31M
--0
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-92.34%-14.93M
-42.24%-15.78M
-56.70%-15.67M
-3.26%-37.36M
---8.5M
---7.76M
---11.1M
---10M
---36.18M
Investing cash flow
Cash flow from continuing investing activities
-208.08%-305K
37.50%-35K
0
-158.25%-266K
0
-99K
-56K
-111K
-103K
Net PPE purchase and sale
-208.08%-305K
37.50%-35K
--0
-61.17%-166K
--0
---99K
---56K
---11K
---103K
Net investment purchase and sale
--0
--0
--0
---100K
--0
--0
--0
---100K
--0
Cash from discontinued investing activities
Investing cash flow
-208.08%-305K
37.50%-35K
--0
-158.25%-266K
--0
---99K
---56K
---111K
---103K
Financing cash flow
Cash flow from continuing financing activities
454,107.14%190.68M
-119.10%-2.39M
615.02%168M
1,298.20%34.94M
-1.01M
-42K
12.5M
23.5M
2.5M
Net issuance payments of debt
---1.5M
-112.00%-1.5M
-106.38%-1.5M
1,300.00%35M
---1M
--0
--12.5M
--23.5M
--2.5M
Net preferred stock issuance
--542K
---40K
--169.5M
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
--184K
--422K
--3K
-90.91%4K
--4K
--0
--0
--0
--44K
Net other financing activities
-5,950.00%-2.54M
----
----
-40.00%-63K
---13K
---42K
---4K
---4K
---45K
Cash from discontinued financing activities
Financing cash flow
454,107.14%190.68M
-119.10%-2.39M
615.02%168M
1,298.20%34.94M
---1.01M
---42K
--12.5M
--23.5M
--2.5M
Net cash flow
Beginning cash position
275.17%159.09M
332.28%177.31M
-9.72%24.96M
-54.82%27.64M
--34.53M
--42.4M
--41.02M
--27.64M
--61.18M
Current changes in cash
2,319.72%175.45M
-1,453.38%-18.2M
1,038.14%152.33M
92.05%-2.69M
---9.51M
---7.9M
--1.35M
--13.38M
---33.79M
Effect of exchange rate changes
-265.71%-58K
-140.48%-17K
258.33%19K
--0
---65K
--35K
--42K
---12K
--246K
End cash Position
868.54%334.47M
275.17%159.09M
332.28%177.31M
-9.72%24.96M
--24.96M
--34.53M
--42.4M
--41.02M
--27.64M
Free cash flow
-93.79%-15.24M
-41.83%-15.82M
-56.53%-15.67M
-3.43%-37.53M
---8.5M
---7.86M
---11.15M
---10.01M
---36.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -92.34%-14.93M-42.24%-15.78M-56.70%-15.67M-3.26%-37.36M-8.5M-7.76M-11.1M-10M-36.18M
Net income from continuing operations -60.05%-23.41M20.98%-13.58M-17.21%-12.99M-60.75%-63.85M---20.96M---14.63M---17.19M---11.08M---39.72M
Operating gains losses -89.21%306K-96.59%70K1,128.57%258K43,973.91%10.09M--5.18M--2.84M--2.05M--21K---23K
Depreciation and amortization -20.83%38K22.50%49K0.00%33K25.58%162K--41K--48K--40K--33K--129K
Other non cash items -97.26%53K-97.01%60K37.03%877K6,413.00%6.51M--1.94M--1.93M--2M--640K--100K
Change In working capital 382.65%6.23M-418.53%-3.94M-1,262.32%-4.7M744.03%6.71M--4.53M--1.29M--1.24M---345K--795K
-Change in prepaid assets -127.38%-23K-87.91%-684K-794.07%-937K223.33%37K--182K--84K---364K--135K---30K
-Change in payables and accrued expense 553.09%9.54M-301.75%-3.23M-683.96%-3.76M605.07%3.34M--4.32M---2.11M--1.6M---480K--473K
-Change in other current assets -------------92.90%25K------------------352K
-Change in other working capital --------------3.31M--0----------------
Cash from discontinued investing activities
Operating cash flow -92.34%-14.93M-42.24%-15.78M-56.70%-15.67M-3.26%-37.36M---8.5M---7.76M---11.1M---10M---36.18M
Investing cash flow
Cash flow from continuing investing activities -208.08%-305K37.50%-35K0-158.25%-266K0-99K-56K-111K-103K
Net PPE purchase and sale -208.08%-305K37.50%-35K--0-61.17%-166K--0---99K---56K---11K---103K
Net investment purchase and sale --0--0--0---100K--0--0--0---100K--0
Cash from discontinued investing activities
Investing cash flow -208.08%-305K37.50%-35K--0-158.25%-266K--0---99K---56K---111K---103K
Financing cash flow
Cash flow from continuing financing activities 454,107.14%190.68M-119.10%-2.39M615.02%168M1,298.20%34.94M-1.01M-42K12.5M23.5M2.5M
Net issuance payments of debt ---1.5M-112.00%-1.5M-106.38%-1.5M1,300.00%35M---1M--0--12.5M--23.5M--2.5M
Net preferred stock issuance --542K---40K--169.5M----------0--0--0----
Proceeds from stock option exercised by employees --184K--422K--3K-90.91%4K--4K--0--0--0--44K
Net other financing activities -5,950.00%-2.54M---------40.00%-63K---13K---42K---4K---4K---45K
Cash from discontinued financing activities
Financing cash flow 454,107.14%190.68M-119.10%-2.39M615.02%168M1,298.20%34.94M---1.01M---42K--12.5M--23.5M--2.5M
Net cash flow
Beginning cash position 275.17%159.09M332.28%177.31M-9.72%24.96M-54.82%27.64M--34.53M--42.4M--41.02M--27.64M--61.18M
Current changes in cash 2,319.72%175.45M-1,453.38%-18.2M1,038.14%152.33M92.05%-2.69M---9.51M---7.9M--1.35M--13.38M---33.79M
Effect of exchange rate changes -265.71%-58K-140.48%-17K258.33%19K--0---65K--35K--42K---12K--246K
End cash Position 868.54%334.47M275.17%159.09M332.28%177.31M-9.72%24.96M--24.96M--34.53M--42.4M--41.02M--27.64M
Free cash flow -93.79%-15.24M-41.83%-15.82M-56.53%-15.67M-3.43%-37.53M---8.5M---7.86M---11.15M---10.01M---36.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+0.05%